P. Donnan

First name
P.
Middle name
T.
Last name
Donnan
Livingstone, S. J., Guthrie, B., McMinn, M., Eke, C., Donnan, P. T., & Morales, D. R. (2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2
View
Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
View
Morales, D. R., Donnan, P. T., Daly, F., Staa, T. V., & Sullivan, F. M. (2013). Impact of clinical trial findings on Bell\textquoterights palsy management in general practice in the UK 2001-2012: interrupted time series regression analysis. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003121
View
Morales, D. R., Dreischulte, T., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006
View
Morales, D. R., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2017). Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. http://doi.org/10.1186/s12916-017-0781-0
View
Morales, D. R., Lipworth, B. J., Donnan, P. T., & Wang, H. (2021). Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2021.04.055
View
Livingstone, S., Morales, D. R., Donnan, P. T., Payne, K., Thompson, A. J., Youn, J. H., & Guthrie, B. (2021). Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(21)00088-x
View